4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-022238
President and CEO sold 4,807 shares at $19.48 ($93,640)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2020-03-30 | Sale | −4,807 | $19.48 | $93,640 | 22,013 | D |
| Open-market sales · 4,807 sh · avg $19.48 · $93,640 | |||||||
Loading xslF345X03/doc4.xml…